Sanctus Global Formulations Limited - Company Profile

It is a pharma public limited company based in Chandigarh, Chandigarh, India, established in 2000.
2000 Chandigarh, Chandigarh, India Active
Last Updated:
Access Report
About Sanctus Global Formulations Limited

Sanctus Global Formulations Limited, a active public limited company, was established on 21 November 2000 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U29297CH2000PLC041530. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹4.16 Cr.

Formerly known as Crescent Therapeutics Limited, Crescent Therapeutics Private Limited. It upholds a compliant status. Employing 108 professional, Its leadership includes Vijay Kumar Joshi (Director), Sahil Joshi (Director), Sangeeta Joshi (Director). Past directors included Vinod Kumar Joshi, Vijay Kumar Joshi, Satya Venkata Raghava Subba Rao Chaganti. It holds ₹26.87 Cr open charges and ₹34.67 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco-56-57 (3Rd Floor) Sector 17-D, Chandigarh, Chandigarh, 160017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U29297CH2000PLC041530

  • Registration Number

    041530

  • Incorporation Date

    21 November 2000

  • Authorized Capital

    ₹4.50 Cr

  • Paid-Up Capital

    ₹4.16 Cr

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.50 Cr
  • Paid Up Capital ₹ 4.16 Cr
  • Company Age 25 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 26.87 Cr
  • Satisfied Charges ₹ 34.67 Cr
  • Revenue Growth **** -4.65%
  • Profit Growth **** 6.11%
  • Ebitda **** 22.69%
  • Net Worth -13.99%
  • Total Assets **** 8.18%
Company report

Sanctus Global Formulations Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sanctus Global Formulations Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sanctus Global Formulations Limited?
Current Directors
Name Designation Appointment Date Status
Vijay Kumar Joshi Director 01 Oct 2016 Current
Sahil Joshi Director 02 Dec 2016 Current
Sangeeta Joshi Director 06 Jan 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2017 Past
Pramod Abcsdd Director 27 Mar 2012 Past
Pramod Abcsdd Whole-Time Director 09 Aug 2010 Past
Pramod Abcsdd Managing Director 01 Oct 2016 Past
Pramod Abcsdd Director 01 Oct 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sanctus Global Formulations.

Sanctus Global Formulations Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 4.65% decrease. The company also saw a slight improvement in profitability, with a 6.11% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.99%.

Sanctus Global Formulations revenue growth over time
Sanctus Global Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -4.65%
*******
*******
*******
*******
Revenue from Operations
*******
 -4.17%
*******
*******
*******
*******
Total Assets
*******
 8.18%
*******
*******
*******
*******
Profit or Loss
*******
 6.11%
*******
*******
*******
*******
Net Worth
*******
 -13.99%
*******
*******
*******
*******
EBITDA
*******
 22.69%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sanctus Global Formulations?

In 2024, Sanctus Global Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹268,659,565.00

Satisfied Charges

₹346,658,761.00

Charges Breakdown by Lending Institutions
  • Others : 26.81 Cr
  • Icici Bank Limited : 0.06 Cr
Latest Charge Details
Date Lender Amount Status
11 Nov 2025 Others ₹7.40 Cr Open
22 Jul 2025 Others ₹1.00 Cr Open
12 Jun 2025 Others ₹3.90 M Open
01 Jan 2024 Others ₹3.00 Cr Open
23 Nov 2022 Others ₹1.25 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Sanctus Global Formulations?

Sanctus Global Formulations has a workforce of 108 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sanctus Global Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanctus Global Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sanctus Global Formulations
Recent Activity within the Organization
  • Charges

    The activity A charge with Others amounted to Rs. 7.40 Cr with Charge ID 101193796 was registered on 11 Nov 2025. was completed.

  • Charges

    A charge with Others amounted to Rs. 1.00 Cr with Charge ID 101132330 was registered on 22 Jul 2025. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 0.39 Cr with Charge ID 101148849 was registered on 12 Jun 2025. was recorded as a recent event.

  • Annual General Meeting

    Progress on Sanctus Global Formulations Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Sanctus Global Formulations Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.

  • Charges

    A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100848324 was registered on 01 Jan 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sanctus Global Formulations Limited?

The CIN of Sanctus Global Formulations Limited is U29297CH2000PLC041530.

Where is Sanctus Global Formulations Limited headquartered?

Sanctus Global Formulations Limited is headquartered at Sco-56-57 (3Rd Floor) Sector 17-D, Chandigarh, Chandigarh, 160017.

When was Sanctus Global Formulations Limited incorporated?

Sanctus Global Formulations Limited was incorporated on 21 November 2000.

Who are the current directors of Sanctus Global Formulations Limited?

The current directors of Sanctus Global Formulations Limited are

What is the primary industry of Sanctus Global Formulations Limited?

The primary industry of Sanctus Global Formulations Limited is Manufacturing.

Is Sanctus Global Formulations Limited a listed company?

Sanctus Global Formulations Limited is unlisted.

What is the capital structure of Sanctus Global Formulations Limited?

The authorized capital of Sanctus Global Formulations Limited is ₹4.50 Cr, and the paid-up capital is ₹4.16 Cr.

What is the compliance status of Sanctus Global Formulations Limited?

The compliance status of Sanctus Global Formulations Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available